Experimental ALS Drug Will Not Be Approved

THURSDAY, Sept. 28, 2023 -- An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending a stem cell-based experimental treatment for amyotrophic lateral sclerosis (ALS).
Although the FDA is not...